Avondet v. Blankstein

118 Ohio App. 3d 357
CourtOhio Court of Appeals
DecidedFebruary 24, 1997
DocketNos. 69934, 69935.
StatusPublished
Cited by34 cases

This text of 118 Ohio App. 3d 357 (Avondet v. Blankstein) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Avondet v. Blankstein, 118 Ohio App. 3d 357 (Ohio Ct. App. 1997).

Opinion

Porter, Judge.

Defendant-appellant and cross-appellee Josef Blankstein, M.D., appeals in case No. 69934 from the jury verdict and damage award of $30,000 in favor of plaintiff-appellee and cross-appellant Donna Avondet, f.k.a. Donna Gambitta, for medical malpractice in the failure to provide the patient with complete cautionary instructions for the contraceptive marketed under the trade name “Norplant.” The cross-appellant appeals in case No. 69935 from the failure of the trial court to *360 award prejudgment interest. For the reasons adduced below, case No. 69934 is affirmed and case No. 69935 is overruled.

A review of the record on appeal indicates that five witnesses testified at the trial on behalf of the plaintiff. The first witness, Mrs. Susan Mulac, testified in pertinent part as follows: (1) she is a close friend and neighbor of the plaintiff; (2) in April 1992, she was shown by plaintiff a newspaper article describing the Norplant system and mentioning the name of the defendant; (3) the witness was present when the plaintiff telephoned the office of the defendant to obtain more information concerning the Norplant system; (4) the witness was aware that the plaintiff had made an appointment to meet with the defendant; (5) after the implant was done, the plaintiff, having received a pamphlet from the defendant concerning the Norplant system, told the witness that another method of birth control had to be used during the first twenty-four hours following the implant, after which time the patient was considered safe from pregnancy; (6) the plaintiff was very depressed upon learning on June 29 that she was pregnant after having the Norplant implanted in her arm by the defendant; (7) the plaintiff terminated this pregnancy by means of an abortion; (8) before having the abortion, the plaintiff received information from another doctor concerning the Norplant system, which indicated that Norplant, if implanted after the menstrual period, would not prevent a pregnancy until after the next menstrual period had occurred; (9) the witness is not aware of what the defendant told the plaintiff while at the defendant’s office or what information was provided her.

The second witness for the plaintiff was Mrs. Barbara Evans, who testified as follows: (1) she has been a friend of the plaintiff since the spring of 1986; (2) an article in a newspaper concerning the Norplant system, which the witness and plaintiff read together, stated that “if Norplant is inserted at the correct time of the menstrual cycle, the woman is protected within 24 hours”; (3) the plaintiff contacted the defendant’s office for more information on the Norplant system; (4) the witness accompanied the plaintiff to the visit at the defendant’s office on May 29, 1992, where a nurse spoke with them concerning the Norplant system, telling them that the system was effective within twenty-four hours of implantation; (5) the witness and plaintiff were given a folder concerning the Norplant system, which stated the following: “The contraceptive effect * * * is reached within 24 hours; therefore, if the capsules are inserted during menses, you may resume sexual relations as soon as you wish”; (6) Plaintiffs Exhibit 2-A, which was printed on December 10, 1990, states the following: “Implantation of all six capsules should be performed during the first seven days of the onset of menses by the health care professional as instructed in the Norplant System insertion technique”; (7) she does not recall seeing the information identified as Plaintiffs Exhibit 5, a document titled Norplant System levonorgestrel implants, at the *361 doctor’s office; (8) at that office visit, they next met with the defendant, who answered the same questions as the nurse; (9) the plaintiff was very upset about the fact that she was pregnant after having.the Norplant implanted; (10) the plaintiff received additional information concerning Norplant from another doctor following the news of her pregnancy, which conditioned the twenty-four-hour effective time to having the implant procedure done during the menses only; (11) on cross-examination, the witness stated that she and the plaintiff did not read the information provided by the doctor in its entirety; (12) the defendant answered all questions that were put to him by the -witness and the plaintiff over the two-and-one-half-hour office visit, which concluded with the implants being done at approximately 12:45 p.m. on May 29, 1992; (13) the defendant never said that the patient could have unprotected sex following the implant procedure.

The third witness for the plaintiff, as if on cross-examination, was the defendant, who stated the following: (1) he has been practicing medicine since 1970, specializing in obstetrics and gynecology; (2) when seen by the witness, the plaintiff was eleven days past the onset of her last menstrual period, which began on the nineteenth of the month, so the Norplant system, which consists of six capsules containing a total of two hundred sixteen milligrams (thirty-six milligrams per capsule) of the progestin levonorgestral, was effective only after her next menstrual period; (3) he does not know when the plaintiff conceived the aborted child; (4) given that conception is not possible for five days following the onset of menstruation, the earliest plaintiff could have conceived was May 24, 1992; (5) an ultrasound, when used to determine the date of conception, is accurate within a range of plus or minus 4.7 days; (6) plaintiffs ultrasound was performed on July 17,1992, and indicated a conception date of May 29,1992 (plus or minus 4.7 days); (7) he did not know if plaintiff was pregnant at the time of the May 29, 1992 office visit; (8) Plaintiffs Exhibit 2-A, an informational brochure which is provided in the Norplant system kit to the medical provider, states, “Insertion should be performed within seven days from the onset of menses; however, Norplant System capsules may be inserted at any time during the cycle, provided pregnancy has been excluded and nonhormonal contraceptive method is used for the remainder of this cycle.”; (9) the plaintiff was not menstruating, ie., bleeding, at the time of her office visit on May 29, 1992, but was using another contraceptive method (condoms) with a ten-percent failure rate; (10) based on this use of an alternative method of contraception and a physical examination, he did not suspect that the plaintiff was pregnant; (11) it is possible that the plaintiff was ovulating at the time of the May 29 office visit; (12) the plaintiff, prior to the implants, did sign a consent form prepared by the defendant which indicated that she had read the Norplant system information, that this information was explained to her, and that she understood that conception was still a possibility despite the implants.

*362 The fourth witness for the plaintiff was Scott Avondet, the husband of the plaintiff, who corroborated the testimony of his wife, adding the following: (1) he began dating his wife in late 1991, and married her on July 7,1993; (2) he and his wife became sexually intimate starting in March 1992; (3) he and his wife had no sexual intercourse during the week preceding the May 29 office visit.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paganini v. Cataract Eye Ctr. of Cleveland
2025 Ohio 275 (Ohio Court of Appeals, 2025)
Ladd v. Planchak
2024 Ohio 24 (Ohio Court of Appeals, 2024)
Waetcher v. Laser Spine Inst., L.L.C.
2023 Ohio 3715 (Ohio Court of Appeals, 2023)
Geletka v. MetroHealth Sys.
2023 Ohio 934 (Ohio Court of Appeals, 2023)
Simon v. Aulino
2020 Ohio 6962 (Ohio Court of Appeals, 2020)
Rashid v. McClymonds Bldg. Ents., Ltd.
2019 Ohio 2817 (Ohio Court of Appeals, 2019)
Telecom Acquisition Corp. I, Inc. v. Lucic Ents., Inc.
2016 Ohio 1466 (Ohio Court of Appeals, 2016)
Link v. FirstEnergy Corp.
2014 Ohio 5432 (Ohio Court of Appeals, 2014)
State Farm Mut. Auto. Ins. Co. v. Williams
2013 Ohio 3884 (Ohio Court of Appeals, 2013)
Wood v. Harborside Healthcare
2012 Ohio 156 (Ohio Court of Appeals, 2012)
Winegar v. Creekside Crossing Home Sales, 08ca001 (11-7-2008)
2008 Ohio 5835 (Ohio Court of Appeals, 2008)
Wright v. Suzuki Motor, Unpublished Decision (6-27-2005)
2005 Ohio 3494 (Ohio Court of Appeals, 2005)
Bicudo v. Lexford Properties, Inc.
812 N.E.2d 315 (Ohio Court of Appeals, 2004)
Chesney v. Jowers, Unpublished Decision (12-11-2003)
2003 Ohio 6614 (Ohio Court of Appeals, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
118 Ohio App. 3d 357, Counsel Stack Legal Research, https://law.counselstack.com/opinion/avondet-v-blankstein-ohioctapp-1997.